Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Two NIH grants awarded to Atrix for preclinical studies on Atrigel polymer system

Dec. 11, 1998

CIMA reports significant transmucosal absorption-enhancing effects for OraVescent

Dec. 9, 1998

Major R&D agreement signed by two German companies

Dec. 8, 1998

CuraGen, Glaxo Wellcome initiate collaborative pharmacogenomics-based drug discovery effort

Dec. 7, 1998

Atrix acquires ViroTex and expands drug delivery technology base

Dec. 4, 1998

Isis sublicenses technology for designing improved antisense drugs

Dec. 2, 1998

Novel injectable drug delivery technology in-licensed by Medi-Ject

Dec. 2, 1998

Jenner Biotherapies receives patent on improved vaccine formulation

Dec. 1, 1998

Transkaryotic Therapies extends agreement with PolyMASC to include second drug candidate

Nov. 30, 1998

Inex receives patent protection for vital component of TCS delivery system

Nov. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...